TABLE 3.
Variables | Odds Ratio | 95% CI | P Valuea |
---|---|---|---|
Clinical inertia(ref: treatment intensification) | - | - | - |
Baseline age category, years (ref: < 50 years) | - | - | - |
50-54 years | 1.16 | (0.92-1.47) | 0.211 |
55-59 years | 1.20 | (0.96-1.50) | 0.113 |
60-64 years | 1.08 | (0.86-1.37) | 0.511 |
≥ 65 years | 2.11 | (1.63-2.74) | < 0.001 |
Male (ref: female) | 1.01 | (0.86-1.19) | 0.902 |
Race (ref: white) | - | - | - |
Nonwhite | 1.32 | (0.94-1.84) | 0.105 |
Missing | 0.99 | (0.75-1.31) | 0.953 |
Baseline A1c ≥ 9.0%(Ref: A1c ≥ 8.0% to < 9.0%) | 0.56 | (0.48-0.66) | < 0.001 |
Baseline number of antihyperglycemic medications (ref: 0) | - | - | - |
1 | 0.75 | (0.61-0.91) | 0.004 |
2 | 1.51 | (1.22-1.86) | <0.001 |
≥ 3 | 1.78 | (1.30-2.42) | <0.001 |
Receiving diabetic counseling at baseline | 0.91 | (0.66-1.24) | 0.547 |
Baseline comorbidities | - | - | - |
Anxiety | 0.95 | (0.72-1.26) | 0.733 |
Depression | 1.10 | (0.86-1.39) | 0.451 |
Severe mental illness | 1.11 | (0.81-1.50) | 0.516 |
Hypertension | 1.09 | (0.92-1.30) | 0.326 |
Dyslipidemia | 1.03 | (0.86-1.22) | 0.766 |
Obesity | 0.81 | (0.65-1.00) | 0.054 |
Coronary heart disease | 1.44 | (1.10-1.88) | 0.007 |
Chronic kidney disease | 0.99 | (0.64-1.51) | 0.953 |
Nephropathy | 1.47 | (0.87-2.48) | 0.150 |
Neuropathy | 1.00 | (0.66-1.50) | 0.993 |
Retinopathy | 1.20 | (0.73-1.96) | 0.464 |
aP values for statistical significance were obtained from the logistic regression model; bolded P values indicate statistical significance.
A1c = hemoglobin A1c; CI = confidence interval; ref = reference.